Laura Grunewald

Statistics

Publications

Citations

277

H-Index

Active since

2019

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

Charité - Universitätsmedizin Berlin

Heidelberg University

Humboldt-Universität zu Berlin

Freie Universität Berlin

Laura Grunewald is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in immunotherapy, oncology, and neuroblastoma biology.

ORCID

Publications per year

2019–2023

Publications

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

Lena Andersch, Josefine Radke, Anika Klaus et al. · BMC Cancer · 2019 · 70 citations · Full text

Medicine, Cancer Biology, Oncology +16

A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization

Laura Grunewald, Tobias Lam, Lena Andersch et al. · Frontiers in Immunology · 2021 · 57 citations · Full text

Life Sciences, Immunology, Oncology +17

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

Ana Textor, Laura Grunewald, Kathleen Anders et al. · Cancers · 2021 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy

Solin Ali, Karin Toews, Silke Schwiebert et al. · Frontiers in Immunology · 2020 · 37 citations · Full text

Life Sciences, Immunology, Oncology +17

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma

Felix Zirngibl, Sara Marie Ivasko, Laura Grunewald et al. · Journal for ImmunoTherapy of Cancer · 2021 · 22 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 8